120 related articles for article (PubMed ID: 38925462)
21. Sexual Dimorphism in a Reciprocal Interaction of Ryanodine and IP
Khomula EV; Ferrari LF; Araldi D; Levine JD
J Neurosci; 2017 Feb; 37(8):2032-2044. PubMed ID: 28115480
[TBL] [Abstract][Full Text] [Related]
22. MNK1 and MNK2 expression in the human dorsal root and trigeminal ganglion.
Shiers S; Sahn JJ; Price TJ
bioRxiv; 2023 Jan; ():. PubMed ID: 36711529
[TBL] [Abstract][Full Text] [Related]
23. Ephrin-B2-induced cleavage of EphB2 receptor is mediated by matrix metalloproteinases to trigger cell repulsion.
Lin KT; Sloniowski S; Ethell DW; Ethell IM
J Biol Chem; 2008 Oct; 283(43):28969-79. PubMed ID: 18713744
[TBL] [Abstract][Full Text] [Related]
24. Vinorelbine causes a neuropathic pain-like state in mice via STING and MNK1 signaling associated with type I interferon induction.
Franco-Enzástiga Ú; Natarajan K; David ET; Patel K; Ravirala A; Price TJ
iScience; 2024 Feb; 27(2):108808. PubMed ID: 38303713
[TBL] [Abstract][Full Text] [Related]
25. Involvement of endothelial ephrin-B2 in adhesion and transmigration of EphB-receptor-expressing monocytes.
Pfaff D; Héroult M; Riedel M; Reiss Y; Kirmse R; Ludwig T; Korff T; Hecker M; Augustin HG
J Cell Sci; 2008 Nov; 121(Pt 22):3842-50. PubMed ID: 18957513
[TBL] [Abstract][Full Text] [Related]
26. Regulation of vasculogenesis and angiogenesis by EphB/ephrin-B2 signaling between endothelial cells and surrounding mesenchymal cells.
Oike Y; Ito Y; Hamada K; Zhang XQ; Miyata K; Arai F; Inada T; Araki K; Nakagata N; Takeya M; Kisanuki YY; Yanagisawa M; Gale NW; Suda T
Blood; 2002 Aug; 100(4):1326-33. PubMed ID: 12149214
[TBL] [Abstract][Full Text] [Related]
27. Ephrin-B2 signaling in the spinal cord as a player in post-inflammatory and stress-induced visceral hypersensitivity.
Theofanous SA; Florens MV; Appeltans I; Denadai Souza A; Wood JN; Wouters MM; Boeckxstaens GE
Neurogastroenterol Motil; 2020 Apr; 32(4):e13782. PubMed ID: 32004400
[TBL] [Abstract][Full Text] [Related]
28. Reversal of peripheral nerve injury-induced neuropathic pain and cognitive dysfunction via genetic and tomivosertib targeting of MNK.
Shiers S; Mwirigi J; Pradhan G; Kume M; Black B; Barragan-Iglesias P; Moy JK; Dussor G; Pancrazio JJ; Kroener S; Price TJ
Neuropsychopharmacology; 2020 Feb; 45(3):524-533. PubMed ID: 31590180
[TBL] [Abstract][Full Text] [Related]
29. Ephrin-B reverse signaling controls septation events at the embryonic midline through separate tyrosine phosphorylation-independent signaling avenues.
Dravis C; Henkemeyer M
Dev Biol; 2011 Jul; 355(1):138-51. PubMed ID: 21539827
[TBL] [Abstract][Full Text] [Related]
30. EphrinB2-EphB2 signaling for dendrite protection after neuronal ischemia
Yu Z; Li W; Lan J; Hayakawa K; Ji X; Lo EH; Wang X
J Cereb Blood Flow Metab; 2021 Jul; 41(7):1744-1755. PubMed ID: 33325764
[TBL] [Abstract][Full Text] [Related]
31. Mnk2 and Mnk1 are essential for constitutive and inducible phosphorylation of eukaryotic initiation factor 4E but not for cell growth or development.
Ueda T; Watanabe-Fukunaga R; Fukuyama H; Nagata S; Fukunaga R
Mol Cell Biol; 2004 Aug; 24(15):6539-49. PubMed ID: 15254222
[TBL] [Abstract][Full Text] [Related]
32. MNK inhibitor eFT508 (Tomivosertib) suppresses ectopic activity in human dorsal root ganglion neurons from dermatomes with radicular neuropathic pain.
Li Y; Uhelski ML; North RY; Mwirigi JM; Tatsui CE; Cata JP; Corrales G; Price TJ; Dougherty PM
bioRxiv; 2023 Jun; ():. PubMed ID: 37398249
[TBL] [Abstract][Full Text] [Related]
33. EphB2 and two of its ligands have dynamic protein expression patterns in the developing olfactory system.
St John JA; Key B
Brain Res Dev Brain Res; 2001 Jan; 126(1):43-56. PubMed ID: 11172885
[TBL] [Abstract][Full Text] [Related]
34. The phosphorylation of ephrin-B2 ligand promotes glioma cell migration and invasion.
Nakada M; Anderson EM; Demuth T; Nakada S; Reavie LB; Drake KL; Hoelzinger DB; Berens ME
Int J Cancer; 2010 Mar; 126(5):1155-65. PubMed ID: 19728339
[TBL] [Abstract][Full Text] [Related]
35. Ephrin-B stimulation of calvarial bone formation.
Benson MD; Opperman LA; Westerlund J; Fernandez CR; San Miguel S; Henkemeyer M; Chenaux G
Dev Dyn; 2012 Dec; 241(12):1901-10. PubMed ID: 23129351
[TBL] [Abstract][Full Text] [Related]
36. Forward signaling by EphB1/EphB2 interacting with ephrin-B ligands at the optic chiasm is required to form the ipsilateral projection.
Chenaux G; Henkemeyer M
Eur J Neurosci; 2011 Nov; 34(10):1620-33. PubMed ID: 22103419
[TBL] [Abstract][Full Text] [Related]
37. Ephrin B/EphB in neuropathic pain: Role and molecular mechanisms.
Kaur S; Bali A; Singh N; Jaggi AS
Fundam Clin Pharmacol; 2024 Feb; 38(1):4-12. PubMed ID: 37401197
[TBL] [Abstract][Full Text] [Related]
38. EphB2-dependent signaling promotes neuronal excitotoxicity and inflammation in the acute phase of ischemic stroke.
Ernst AS; Böhler LI; Hagenston AM; Hoffmann A; Heiland S; Sticht C; Bendszus M; Hecker M; Bading H; Marti HH; Korff T; Kunze R
Acta Neuropathol Commun; 2019 Feb; 7(1):15. PubMed ID: 30722785
[TBL] [Abstract][Full Text] [Related]
39. Upregulation of EphB2 and ephrin-B2 at the optic nerve head of DBA/2J glaucomatous mice coincides with axon loss.
Du J; Tran T; Fu C; Sretavan DW
Invest Ophthalmol Vis Sci; 2007 Dec; 48(12):5567-81. PubMed ID: 18055806
[TBL] [Abstract][Full Text] [Related]
40. Repelling class discrimination: ephrin-A5 binds to and activates EphB2 receptor signaling.
Himanen JP; Chumley MJ; Lackmann M; Li C; Barton WA; Jeffrey PD; Vearing C; Geleick D; Feldheim DA; Boyd AW; Henkemeyer M; Nikolov DB
Nat Neurosci; 2004 May; 7(5):501-9. PubMed ID: 15107857
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]